Ads
related to: niddk organizational chart
Search results
Results From The WOW.Com Content Network
The NIDDK developed a plan to use its portion of the ARRA funds to meet the stimulus goals set forth in the Recovery Act. This funding supported a range of biomedical research efforts across the institute's research mission. June 15, 2010—H. Res. 1444, a bipartisan resolution recognizing the 60th anniversary of the NIDDK, was introduced.
An organizational chart, also called organigram, organogram, or organizational breakdown structure (OBS), is a diagram that shows the structure of an organization and the relationships and relative ranks of its parts and positions/jobs. The term is also used for similar diagrams, for example ones showing the different elements of a field of ...
The NIDDK is part of the National Institutes of Health, which is under the U.S. Department of Health and Human Services. Established in 1980, the Clearinghouse provides information about digestive diseases to people with digestive disorders and to their families, health care professionals, and the public.
The NIDDK is part of the National Institutes of Health, which is part of the U.S. Department of Health and Human Services. The Endocrine and Metabolic Diseases Information Service is a part of the NIDDK's Division of Diabetes, Endocrinology, and Metabolic Diseases.
The National Institutes of Health (NIH) is the primary agency of the United States government responsible for biomedical and public health research. It was founded in 1887 and is now part of the United States Department of Health and Human Services.
Organization of CDC in 2024, after the CDC Moving Forward reorganization. The CDC Moving Forward reorganization occurred in 2023 as a response to lessons learned from CDC's response to the COVID-19 pandemic. [16] [17] The Deputy Director level was removed, returning CDC to a flat structure. The reorganization did not otherwise organizationally ...
Hoofnagle leads the Liver Disease Research Branch at NIDDK, [4] and has done so since he was tapped for the position in 2003. [5] In this capacity, Hoofnagle oversees the Drug-Induced Liver Injury Network and LiverTox, a database that provides "comprehensive and unbiased information about drug induced liver injury caused by prescription and nonprescription drugs, herbal and dietary supplements."
He became the Chief of the Molecular and Clinical Hematology Branch in 1998 and the NIDDK Deputy Director in 2001. In 2006, he assumed the directorship on an acting basis and this position was made permanent in 2007 by the NIH's director at the time, Elias Zerhouni .